Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug3722 | Standard charity resources Wiki | 1.00 |
| drug716 | COMPASS Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The viral pandemic of the coronavirus disease 2019 (COVID-19), generated by a novel mutated severe acute respiratory syndrome coronavirus (SARS-CoV-2), has become a serious worldwide public health emergency, evolving exponentially. While the main organ targeted in this disease is the lungs, other vital organs, such as the heart and kidney, may be implicated. The main host receptor of the SARS-CoV-2 is angiotensin converting enzyme 2 (ACE2), a major component of the renin-angiotensin-aldosterone system (RAAS). The ACE2 is also involved in testicular male regulation of steroidogenesis and spermatogenesis. As the SARS-CoV-2 may have the potential to infect the testis via ACE2 and adversely affect male reproductive system.
Description: semen analysis taken by 72day of infection to see the effect on the new cycle of spermatogenesis
Measure: changes of semen volume in (ML)by covid-19 from normal values. Time: 72days after infectionDescription: semen analysis taken by 72day of infection to see the effect on the new cycle of spermatogenesis
Measure: changes of sperm concentration in (million/ml) by covid-19 from normal values. Time: 72days after infectionDescription: semen analysis taken by 72day of infection to see the effect on the new cycle of spermatogenesis
Measure: changes of sperm morphology in (percentage of normal forms) by covid-19 from normal values. Time: 72days after infectionDescription: semen analysis taken by 72day of infection to see the effect on the new cycle of spermatogenesis
Measure: changes of sperm motility in percentage of (A+B) by covid-19 from normal values. Time: 72days after infectionDescription: semen analysis taken by 72day of the first negative swab of covid-19 to see the effect on the new cycle of spermatogenesisand to compare with the first sample which done during infection.
Measure: changes of semen volume in (ML) by covid-19 from from the first sample Time: after 72 days of the first sampleDescription: semen analysis taken by 72day of the first negative swab of covid-19 to see the effect on the new cycle of spermatogenesisand to compare with the first sample which done during infection.
Measure: changes of sperm concentration in (million /ML) by covid-19 from from the first sample Time: after 72 days of the first sampleDescription: semen analysis taken by 72day of the first negative swab of covid-19 to see the effect on the new cycle of spermatogenesisand to compare with the first sample which done during infection.
Measure: changes of sperm morphology in percentage of normal form by covid-19 from from the first sample Time: after 72 days of the first sampleDescription: semen analysis taken by 72day of the first negative swab of covid-19 to see the effect on the new cycle of spermatogenesisand to compare with the first sample which done during infection.
Measure: changes of sperm motility in percentage of (A+B) by covid-19 from from the first sample Time: after 72 days of the first sampleAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports